GW Pharmaceuticals - ADR

+0.73 (+0.34%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)6.74B
Current PEN/A
Forward PE N/A
2yr Forward PE 457.4
See more stats
Estimates Current Quarter
Revenue$157.97 Million
Adjusted EPS-$0.03
See more estimates
10-Day MA$212.43
50-Day MA$160.30
200-Day MA$126.88
See more pivots

GW Pharmaceuticals Plc Stock, NASDAQ:GWPH

Sovereign House, Vision Park, Chivers Way, Cambridge, Cambridgeshire CB24 9BZ
Phone: +44.1223.266800
Number of Employees: 901


GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.